The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neoantigen Targeted Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2029
Synopsis
The global Neoantigen Targeted Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.
Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the patient's tumor, screen out mutations that may become neoantigens as targets, and load them on antigen-producing cells (APCs), thereby It has the effect of activating T cells to recognize a variety of new antigens, and then kill tumors.
This report is a detailed and comprehensive analysis for global Neoantigen Targeted Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neoantigen Targeted Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neoantigen Targeted Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neoantigen Targeted Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioNTech SE, Gritstone Bio, Genocea Biosciences, Moderna and Agenus, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Neoantigen Targeted Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Off-the-shelf Neoantigen
Personalized Neoantigen
Market segment by Application
Colorectal Cancer
Renal Cell Carcinoma
Non-Small Cell Lung cancer
Bone Cancer
Gynecological Cancer
Others
Market segment by players, this report covers
BioNTech SE
Gritstone Bio
Genocea Biosciences
Moderna
Agenus
Immatics
Advaxis
Precision Biologics
Gilead Sciences
Cellular Biomedicine Group
Achilles Therapeutics
Merck and Co
Beijing Kati Medical Technology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Neoantigen Targeted Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neoantigen Targeted Therapy, with revenue, gross margin and global market share of Neoantigen Targeted Therapy from 2018 to 2023.
Chapter 3, the Neoantigen Targeted Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Neoantigen Targeted Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Neoantigen Targeted Therapy.
Chapter 13, to describe Neoantigen Targeted Therapy research findings and conclusion.
The global Neoantigen Targeted Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.
Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the patient's tumor, screen out mutations that may become neoantigens as targets, and load them on antigen-producing cells (APCs), thereby It has the effect of activating T cells to recognize a variety of new antigens, and then kill tumors.
This report is a detailed and comprehensive analysis for global Neoantigen Targeted Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neoantigen Targeted Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Neoantigen Targeted Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neoantigen Targeted Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neoantigen Targeted Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioNTech SE, Gritstone Bio, Genocea Biosciences, Moderna and Agenus, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Neoantigen Targeted Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Off-the-shelf Neoantigen
Personalized Neoantigen
Market segment by Application
Colorectal Cancer
Renal Cell Carcinoma
Non-Small Cell Lung cancer
Bone Cancer
Gynecological Cancer
Others
Market segment by players, this report covers
BioNTech SE
Gritstone Bio
Genocea Biosciences
Moderna
Agenus
Immatics
Advaxis
Precision Biologics
Gilead Sciences
Cellular Biomedicine Group
Achilles Therapeutics
Merck and Co
Beijing Kati Medical Technology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Neoantigen Targeted Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neoantigen Targeted Therapy, with revenue, gross margin and global market share of Neoantigen Targeted Therapy from 2018 to 2023.
Chapter 3, the Neoantigen Targeted Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Neoantigen Targeted Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Neoantigen Targeted Therapy.
Chapter 13, to describe Neoantigen Targeted Therapy research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Neoantigen Targeted Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neoantigen Targeted Therapy by Type
1.3.1 Overview: Global Neoantigen Targeted Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Neoantigen Targeted Therapy Consumption Value Market Share by Type in 2022
1.3.3 Off-the-shelf Neoantigen
1.3.4 Personalized Neoantigen
1.4 Global Neoantigen Targeted Therapy Market by Application
1.4.1 Overview: Global Neoantigen Targeted Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Colorectal Cancer
1.4.3 Renal Cell Carcinoma
1.4.4 Non-Small Cell Lung cancer
1.4.5 Bone Cancer
1.4.6 Gynecological Cancer
1.4.7 Others
1.5 Global Neoantigen Targeted Therapy Market Size & Forecast
1.6 Global Neoantigen Targeted Therapy Market Size and Forecast by Region
1.6.1 Global Neoantigen Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Neoantigen Targeted Therapy Market Size by Region, (2018-2029)
1.6.3 North America Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Neoantigen Targeted Therapy Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 BioNTech SE
2.1.1 BioNTech SE Details
2.1.2 BioNTech SE Major Business
2.1.3 BioNTech SE Neoantigen Targeted Therapy Product and Solutions
2.1.4 BioNTech SE Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BioNTech SE Recent Developments and Future Plans
2.2 Gritstone Bio
2.2.1 Gritstone Bio Details
2.2.2 Gritstone Bio Major Business
2.2.3 Gritstone Bio Neoantigen Targeted Therapy Product and Solutions
2.2.4 Gritstone Bio Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gritstone Bio Recent Developments and Future Plans
2.3 Genocea Biosciences
2.3.1 Genocea Biosciences Details
2.3.2 Genocea Biosciences Major Business
2.3.3 Genocea Biosciences Neoantigen Targeted Therapy Product and Solutions
2.3.4 Genocea Biosciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genocea Biosciences Recent Developments and Future Plans
2.4 Moderna
2.4.1 Moderna Details
2.4.2 Moderna Major Business
2.4.3 Moderna Neoantigen Targeted Therapy Product and Solutions
2.4.4 Moderna Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Moderna Recent Developments and Future Plans
2.5 Agenus
2.5.1 Agenus Details
2.5.2 Agenus Major Business
2.5.3 Agenus Neoantigen Targeted Therapy Product and Solutions
2.5.4 Agenus Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Agenus Recent Developments and Future Plans
2.6 Immatics
2.6.1 Immatics Details
2.6.2 Immatics Major Business
2.6.3 Immatics Neoantigen Targeted Therapy Product and Solutions
2.6.4 Immatics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Immatics Recent Developments and Future Plans
2.7 Advaxis
2.7.1 Advaxis Details
2.7.2 Advaxis Major Business
2.7.3 Advaxis Neoantigen Targeted Therapy Product and Solutions
2.7.4 Advaxis Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Advaxis Recent Developments and Future Plans
2.8 Precision Biologics
2.8.1 Precision Biologics Details
2.8.2 Precision Biologics Major Business
2.8.3 Precision Biologics Neoantigen Targeted Therapy Product and Solutions
2.8.4 Precision Biologics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Precision Biologics Recent Developments and Future Plans
2.9 Gilead Sciences
2.9.1 Gilead Sciences Details
2.9.2 Gilead Sciences Major Business
2.9.3 Gilead Sciences Neoantigen Targeted Therapy Product and Solutions
2.9.4 Gilead Sciences Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Gilead Sciences Recent Developments and Future Plans
2.10 Cellular Biomedicine Group
2.10.1 Cellular Biomedicine Group Details
2.10.2 Cellular Biomedicine Group Major Business
2.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Product and Solutions
2.10.4 Cellular Biomedicine Group Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cellular Biomedicine Group Recent Developments and Future Plans
2.11 Achilles Therapeutics
2.11.1 Achilles Therapeutics Details
2.11.2 Achilles Therapeutics Major Business
2.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Product and Solutions
2.11.4 Achilles Therapeutics Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Achilles Therapeutics Recent Developments and Future Plans
2.12 Merck and Co
2.12.1 Merck and Co Details
2.12.2 Merck and Co Major Business
2.12.3 Merck and Co Neoantigen Targeted Therapy Product and Solutions
2.12.4 Merck and Co Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Merck and Co Recent Developments and Future Plans
2.13 Beijing Kati Medical Technology
2.13.1 Beijing Kati Medical Technology Details
2.13.2 Beijing Kati Medical Technology Major Business
2.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Product and Solutions
2.13.4 Beijing Kati Medical Technology Neoantigen Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Beijing Kati Medical Technology Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Neoantigen Targeted Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Neoantigen Targeted Therapy by Company Revenue
3.2.2 Top 3 Neoantigen Targeted Therapy Players Market Share in 2022
3.2.3 Top 6 Neoantigen Targeted Therapy Players Market Share in 2022
3.3 Neoantigen Targeted Therapy Market: Overall Company Footprint Analysis
3.3.1 Neoantigen Targeted Therapy Market: Region Footprint
3.3.2 Neoantigen Targeted Therapy Market: Company Product Type Footprint
3.3.3 Neoantigen Targeted Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Neoantigen Targeted Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Neoantigen Targeted Therapy Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Neoantigen Targeted Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Neoantigen Targeted Therapy Market Forecast by Application (2024-2029)
6 North America
6.1 North America Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
6.2 North America Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
6.3 North America Neoantigen Targeted Therapy Market Size by Country
6.3.1 North America Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
7.2 Europe Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
7.3 Europe Neoantigen Targeted Therapy Market Size by Country
7.3.1 Europe Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.3 France Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Neoantigen Targeted Therapy Market Size by Region
8.3.1 Asia-Pacific Neoantigen Targeted Therapy Consumption Value by Region (2018-2029)
8.3.2 China Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.5 India Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
9 South America
9.1 South America Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
9.2 South America Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
9.3 South America Neoantigen Targeted Therapy Market Size by Country
9.3.1 South America Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Neoantigen Targeted Therapy Market Size by Country
10.3.1 Middle East & Africa Neoantigen Targeted Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Neoantigen Targeted Therapy Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Neoantigen Targeted Therapy Market Drivers
11.2 Neoantigen Targeted Therapy Market Restraints
11.3 Neoantigen Targeted Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Neoantigen Targeted Therapy Industry Chain
12.2 Neoantigen Targeted Therapy Upstream Analysis
12.3 Neoantigen Targeted Therapy Midstream Analysis
12.4 Neoantigen Targeted Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
